Insider · CIK 0001639144

Daruwala Paul

Reports to the SEC for 1 company · SAN DIEGO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001639144

Forms 4 and 5

Insider transactions

36 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2022-09-12	CDTXCidara Therapeutics, Inc.S Sale	Chief Operating Officer	SSale	−16.2K sh	$0.68	−$11.1K	221,099
2022-03-31	CDTXCidara Therapeutics, Inc. · Employee Stock Option (right to buy)A Award	Chief Operating Officer	AAward	+100K sh	—	—	100,000
2022-03-31	CDTXCidara Therapeutics, Inc.A Award	Chief Operating Officer	AAward	+50K sh	—	—	237,298
2022-01-05	CDTXCidara Therapeutics, Inc.S Sale	Chief Operating Officer	SSale	−5,133 sh	$1.25	−$6,416.25	187,298
2021-12-29	CDTXCidara Therapeutics, Inc. · Restricted Stock UnitM Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−4,900 sh	—	—	5,600
2021-12-29	CDTXCidara Therapeutics, Inc.M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+9,900 sh	—	—	192,431
2021-12-29	CDTXCidara Therapeutics, Inc. · Restricted Stock UnitM Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−5,000 sh	—	—	12,500
2021-09-30	CDTXCidara Therapeutics, Inc.A Award	Chief Operating Officer	AAward	+132K sh	—	—	182,531
2021-04-01	CDTXCidara Therapeutics, Inc.S Sale	Chief Operating Officer	SSale	−593 sh	$2.66	−$1,577.38	50,531
2021-03-31	CDTXCidara Therapeutics, Inc.A Award	Chief Operating Officer	AAward	+1,400 sh	—	—	51,124
2021-03-17	CDTXCidara Therapeutics, Inc. · Employee Stock Option (right to buy)A Award	Chief Operating Officer	AAward	+120K sh	—	—	120,000
2021-01-05	CDTXCidara Therapeutics, Inc.S Sale	Chief Operating Officer	SSale	−2,868 sh	$2.06	−$5,908.08	49,724
2020-03-19	CDTXCidara Therapeutics, Inc. · Employee Stock Option (right to buy)A Award	Chief Operating Officer	AAward	+90K sh	—	—	90,000
2020-01-03	CDTXCidara Therapeutics, Inc.S Sale	Chief Operating Officer	SSale	−940 sh	$3.42	−$3,214.8	52,592
2020-01-03	CDTXCidara Therapeutics, Inc.S Sale	Chief Operating Officer	SSale	−2,340 sh	$3.42	−$8,002.8	53,532
2019-12-18	CDTXCidara Therapeutics, Inc. · Employee Stock Option (right to buy)A Award	Chief Operating Officer	AAward	+32.6K sh	—	—	32,592
2019-12-18	CDTXCidara Therapeutics, Inc. · Employee Stock Option (right to buy)D Disposition to Issuer	Chief Operating Officer	DDisposition to Issuer	−25.7K sh	—	—	0
2019-12-18	CDTXCidara Therapeutics, Inc. · Employee Stock Option (right to buy)A Award	Chief Operating Officer	AAward	+17.1K sh	—	—	17,125
2019-12-18	CDTXCidara Therapeutics, Inc. · Employee Stock Option (right to buy)D Disposition to Issuer	Chief Operating Officer	DDisposition to Issuer	−50K sh	—	—	0
2019-12-18	CDTXCidara Therapeutics, Inc. · Employee Stock Option (right to buy)A Award	Chief Operating Officer	AAward	+33.3K sh	—	—	33,333
2019-12-18	CDTXCidara Therapeutics, Inc. · Employee Stock Option (right to buy)D Disposition to Issuer	Chief Operating Officer	DDisposition to Issuer	−55K sh	—	—	0
2019-12-18	CDTXCidara Therapeutics, Inc. · Employee Stock Option (right to buy)A Award	Chief Operating Officer	AAward	+4,074 sh	—	—	4,074
2019-10-02	CDTXCidara Therapeutics, Inc.S Sale	Chief Operating Officer	SSale	−3,295 sh	$1.88	−$6,194.6	55,872
2019-09-12	CDTXCidara Therapeutics, Inc.A Award	Chief Operating Officer	AAward	+2,100 sh	—	—	59,167
2019-09-12	CDTXCidara Therapeutics, Inc.A Award	Chief Operating Officer	AAward	+7,500 sh	—	—	57,067
2019-09-12	CDTXCidara Therapeutics, Inc. · Restricted Stock UnitM Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−7,500 sh	—	—	17,500
2019-09-12	CDTXCidara Therapeutics, Inc. · Restricted Stock UnitM Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−2,100 sh	—	—	11,900
2019-03-21	CDTXCidara Therapeutics, Inc. · Employee Stock Option (right to buy)A Award	Chief Operating Officer	AAward	+77K sh	—	—	77,000
2019-03-07	CDTXCidara Therapeutics, Inc.S Sale	Chief Operating Officer	SSale	−2,240 sh	$2.55	−$5,713.568	49,567
2019-01-31	CDTXCidara Therapeutics, Inc.A Award	Chief Operating Officer	AAward	+6,000 sh	—	—	51,807
2019-01-31	CDTXCidara Therapeutics, Inc. · Restricted Stock UnitM Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+14K sh	—	—	14,000
2018-03-29	CDTXCidara Therapeutics, Inc. · Employee Stock Option (right to buy)A Award	Chief Operating Officer	AAward	+72K sh	—	—	72,000
2017-09-18	CDTXCidara Therapeutics, Inc.A Award	Chief Operating Officer	AAward	+15K sh	—	—	45,807
2017-09-18	CDTXCidara Therapeutics, Inc. · Restricted Stock UnitM Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+25K sh	—	—	25,000
2017-03-31	CDTXCidara Therapeutics, Inc. · Employee Stock Option (right to buy)A Award	Chief Operating Officer	AAward	+55K sh	—	—	55,000
2016-03-16	CDTXCidara Therapeutics, Inc. · Stock Option (right to buy)A Award	Chief Operating Officer	AAward	+50K sh	—	—	50,000

Recent filings

Accepted (ET)
Sep 134
Daruwala Paul0001610618-22-000076
SEC(opens sec.gov)
Apr 44
Daruwala Paul0001610618-22-000019
SEC(opens sec.gov)
Jan 74
Daruwala Paul0001209191-22-002604
SEC(opens sec.gov)
Oct 44
Daruwala Paul0001610618-21-000091
SEC(opens sec.gov)
Apr 54
Daruwala Paul0001610618-21-000031
SEC(opens sec.gov)
Mar 194
Daruwala Paul0001610618-21-000021
SEC(opens sec.gov)
Jun 254/A
Daruwala Paul0001209191-20-039024
SEC(opens sec.gov)
Mar 234
Daruwala Paul0001209191-20-020754
SEC(opens sec.gov)
Jan 64
Daruwala Paul0001209191-20-002030
SEC(opens sec.gov)
Dec 204
Daruwala Paul0001209191-19-061576
SEC(opens sec.gov)

Companies

Cidara Therapeutics, Inc.Chief Operating OfficerCDTX

Address

6310 NANCY RIDGE DRIVE SUITE 101

SAN DIEGO, CA, 92121